BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
April 01, 2024 at 04:46 pm EDT
Share
BioLargo, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 12.23 million compared to USD 5.88 million a year ago. Net loss was USD 3.5 million compared to USD 4.47 million a year ago.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment engaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is engaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.